Related Experiment Video
Updated: Jun 19, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Delirium: pathophysiology, recognition, prevention and treatment
Terry Rabinowitz1, Katharine M Murphy, Keith J Nagle
1University of Vermont College of Medicine, Psychiatric Consultation Service, Fletcher Allen Health Care, Burlington, Vermont, USA. Terry.Rabinowitz@VTMEDNET.ORG
Expert Review of Neurotherapeutics
|October 9, 2009
Summary
Delirium, a state of acute confusion, signals a dangerous physiological imbalance. Early recognition and multidisciplinary intervention are crucial for better patient outcomes and preventing severe complications.
Area of Science:
- Geriatrics
- Critical Care Medicine
- Neurology
Background:
- Delirium is an acute confusional state indicating physiological disruption.
- It often goes unrecognized, leading to adverse outcomes like prolonged hospitalization and cognitive deficits.
- Prompt intervention is vital to prevent mortality.
Purpose of the Study:
- To highlight the significance of recognizing and treating delirium.
- To emphasize the need for coordinated, multidisciplinary approaches in managing delirium.
- To underscore the importance of involving family and caregivers in delirium management.
Main Methods:
- This abstract discusses the clinical presentation and implications of delirium.
- It reviews the consequences of delayed diagnosis and treatment.
- It outlines the essential components of effective prevention and management strategies.
Main Results:
- Untreated delirium is associated with increased hospital stays, persistent cognitive impairment, and higher rates of nursing home placement.
- Effective management requires a coordinated, multidisciplinary approach.
- Family and caregiver involvement is a key factor in successful interventions.
Conclusions:
- Delirium requires prompt recognition and management to improve patient outcomes.
- Multidisciplinary collaboration, including nursing, psychiatry, neurology, and primary care, is essential.
- Engaging family and friends significantly aids in the prevention and treatment of delirium.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...